Eric Furfine

Eric Furfine is the current Co-CEO & Chief Scientific Officer at Mosaic Biosciences. Eric was previously the Chief Scientific Officer at Eleven Biotherapeutics from January 2011 to February 2016, and Senior VP Research and Preclinical Development at Adnexus: A Bristol-Myers Squibb R&D Company from August 2006 to December 2010. From January 2002 to December 2006, they were the VP Preclinical Development at Regeneron. Eric also has experience as the Chief Scientific Officer and Acting Chief Executive Officer at ImmuneXcite from February 2016 to October 2017.

Eric Furfine received their Ph.D. in Biochemistry from Brandeis University and did their postdoctoral work in molecular parasitology at the University of California, San Francisco. Eric holds an A.B. in Chemistry from Washington University in St. Louis.